Skandinaviska Enskilda Banken (SEB)’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.3M | Buy |
1,747,901
+24,700
| +1% | +$414K | 0.13% | 135 |
|
|
2025
Q1 | $26.5M | Buy |
1,723,201
+290,827
| +20% | +$4.47M | 0.13% | 139 |
|
|
2024
Q4 | $32M | Buy |
1,432,374
+172,122
| +14% | +$3.84M | 0.14% | 125 |
|
|
2024
Q3 | $22.7M | Sell |
1,260,252
-16,400
| -1% | -$296K | 0.1% | 165 |
|
|
2024
Q2 | $20.7M | Hold |
1,276,652
| – | – | 0.1% | 170 |
|
|
2024
Q1 | $18M | Buy |
1,276,652
+1,052,552
| +470% | +$14.9M | 0.09% | 197 |
|
|
2023
Q4 | $2.34M | Buy |
224,100
+20,700
| +10% | +$216K | 0.01% | 551 |
|
|
2023
Q3 | $2.08M | Hold |
203,400
| – | – | 0.01% | 537 |
|
|
2023
Q2 | $1.53M | Buy |
203,400
+53,600
| +36% | +$404K | 0.01% | 614 |
|
|
2023
Q1 | $1.33M | Hold |
149,800
| – | – | 0.01% | 643 |
|
|
2022
Q4 | $1.37M | Buy |
149,800
+10,100
| +7% | +$92.1K | 0.01% | 621 |
|
|
2022
Q3 | $1.13M | Sell |
139,700
-42,954
| -24% | -$347K | 0.01% | 652 |
|
|
2022
Q2 | $1.37M | Sell |
182,654
-41,700
| -19% | -$314K | 0.01% | 651 |
|
|
2022
Q1 | $2.11M | Sell |
224,354
-17,748
| -7% | -$167K | 0.01% | 615 |
|
|
2021
Q4 | $1.91M | Sell |
242,102
-23,883
| -9% | -$189K | 0.01% | 656 |
|
|
2021
Q3 | $2.59M | Buy |
265,985
+42,122
| +19% | +$410K | 0.01% | 581 |
|
|
2021
Q2 | $2.22M | Sell |
223,863
-5,907
| -3% | -$58.5K | 0.01% | 638 |
|
|
2021
Q1 | $2.65M | Buy |
229,770
+6,555
| +3% | +$75.7K | 0.02% | 571 |
|
|
2020
Q4 | $2.15M | Sell |
223,215
-30,063
| -12% | -$290K | 0.01% | 629 |
|
|
2020
Q3 | $2.28M | Buy |
253,278
+2,198
| +0.9% | +$19.8K | 0.02% | 533 |
|
|
2020
Q2 | $3.1M | Buy |
251,080
+14,400
| +6% | +$178K | 0.03% | 445 |
|
|
2020
Q1 | $2.13M | Buy |
236,680
+4,350
| +2% | +$39.1K | 0.02% | 457 |
|
|
2019
Q4 | $2.28M | Buy |
232,330
+13,190
| +6% | +$129K | 0.02% | 528 |
|
|
2019
Q3 | $1.51M | Sell |
219,140
-15,780
| -7% | -$109K | 0.01% | 608 |
|
|
2019
Q2 | $2.17M | Buy |
234,920
+18,055
| +8% | +$167K | 0.02% | 490 |
|
|
2019
Q1 | $3.4M | Sell |
216,865
-8,100
| -4% | -$127K | 0.03% | 350 |
|
|
2018
Q4 | $3.47M | Buy |
224,965
+860
| +0.4% | +$13.3K | 0.03% | 344 |
|
|
2018
Q3 | $4.83M | Buy |
224,105
+9,380
| +4% | +$202K | 0.04% | 304 |
|
|
2018
Q2 | $5.22M | Buy |
214,725
+26,750
| +14% | +$651K | 0.04% | 268 |
|
|
2018
Q1 | $3.21M | Buy |
187,975
+7,785
| +4% | +$133K | 0.03% | 289 |
|
|
2017
Q4 | $3.42M | Buy |
180,190
+24,225
| +16% | +$459K | 0.03% | 343 |
|
|
2017
Q3 | $2.75M | Buy |
155,965
+65,740
| +73% | +$1.16M | 0.02% | 401 |
|
|
2017
Q2 | $3M | Buy |
90,225
+9,400
| +12% | +$312K | 0.03% | 386 |
|
|
2017
Q1 | $2.59M | Sell |
80,825
-73
| -0.1% | -$2.34K | 0.03% | 398 |
|
|
2016
Q4 | $2.93M | Sell |
80,898
-582,902
| -88% | -$21.1M | 0.04% | 312 |
|
|
2016
Q3 | $30.5M | Sell |
663,800
-39,175
| -6% | -$1.8M | 0.33% | 65 |
|
|
2016
Q2 | $35.3M | Sell |
702,975
-217,400
| -24% | -$10.9M | 0.4% | 55 |
|
|
2016
Q1 | $49.2M | Sell |
920,375
-61,800
| -6% | -$3.31M | 0.55% | 35 |
|
|
2015
Q4 | $64.5M | Buy |
+982,175
| New | +$64.5M | 0.84% | 24 |
|